Rintu Sharma
Overview
Explore the profile of Rintu Sharma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singh S, Sharma R, Singh J, Jain K, Kumar R, Narang V
Natl Med J India
. 2024 Oct;
37(3):138-140.
PMID: 39399996
Background Autologous stem cell transplantation (ASCT) is potentially beneficial for patients with myeloma-related renal impairment but is associated with high rates of complications in dialysis-dependent patients and requires specific precautions....
2.
Singh S, Sharma R, Singh J, Jain K, Kaur G, Gupta V, et al.
Indian J Hematol Blood Transfus
. 2024 Jul;
40(3):423-431.
PMID: 39011248
Supplementary Information: The online version contains supplementary material available at 10.1007/s12288-024-01757-3.
3.
Singh S, Sharma R, Singh J, Jain K, Paul D
J Cancer Res Ther
. 2023 May;
19(Supplement):S12-S19.
PMID: 37147978
Treatment of multiple myeloma has undergone significant advances in the last two decades, leading to meaningful improvement in overall and progression free survival. The incurable nature of disease necessitates serial...
4.
Singh S, Raj S, Therese M, Sharma R, Jain K
Indian J Pathol Microbiol
. 2023 Apr;
66(2):418-421.
PMID: 37077102
No abstract available.
5.
Singh S, Singh J, Mehta A, Sharma R, Joshi K, Jain K, et al.
Clin Lymphoma Myeloma Leuk
. 2023 Feb;
23(5):360-369.e1.
PMID: 36849307
Introduction: We report one of the largest single center data from a mixed referral setting in India describing baseline characteristics and outcomes of patients with classical BCR::ABL1 negative myeloproliferative neoplasms...
6.
Sharma R, Jain A, Jandial A, Lad D, Khadwal A, Prakash G, et al.
Clin Lymphoma Myeloma Leuk
. 2022 May;
22(8):626-634.
PMID: 35610119
Background: Renal impairment (RI) confers a poor prognosis in multiple myeloma. Reversibility of renal function is associated with improved survival in such patients. Patients in developing countries often present at...
7.
Singh S, Sharma R, Singh J, Jain K, Paul D
J Pediatr Hematol Oncol
. 2021 Sep;
43(7):243-248.
PMID: 34550107
Thrombocytopenia is noted in corona virus disease-2019 (COVID-19) with a prevalence of 5% to 41%, and has been observed to be associated with inferior outcomes. The pathogenesis of thrombocytopenia in...
8.
Sharma R, Singh C, Khadwal A, Prakash G, Malhotra P, Jain A, et al.
Transpl Infect Dis
. 2021 May;
23(4):e13632.
PMID: 33973316
Introduction: The role of pre-HCT chest high-resolution computed tomography (HRCT) and serum galactomannan index (GMI) in predicting the post-allogeneic hematopoietic cell transplant (HCT) invasive pulmonary aspergillosis (IPA) is debatable. Methods:...
9.
Adiga S, Mehta A, Singh U, Singh C, Sharma R, Banerjee N, et al.
Eur J Ophthalmol
. 2020 Nov;
32(1):NP246-NP250.
PMID: 33183084
Purpose: Ocular adnexal lymphomas (OAL) constitute 55% of all orbital tumors. Waldenström Macroglobulinemia (WM) presenting as an orbital mass with diffuse extraocular muscle (EOM) involvement is rare. We report an...
10.
Kaundal R, Bhatia P, Jain A, Jain A, Nampoothiri R, Mishra K, et al.
Ann Hematol
. 2019 Dec;
99(1):57-63.
PMID: 31811360
Recent studies in iron-depleted women have challenged the current approach of treating iron-deficiency anemia (IDA) with oral iron in divided daily doses. Alternate day dosing leads to more fractional absorption...